Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and AustraliaAdriano Lazzarin, Miklos Salgo, Bonaventura Clotet et al.|New England Journal of Medicine|2003Cited by 653
Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical TrialsMark Nelson, Miklos Salgo, Keikawus Arastéh et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005Cited by 151
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis CM. Colombo, Heiner Wedemeyer, A. Verheyen et al.|Gut|2013Cited by 46
Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access programMassimo Colombo, Heiner Wedemeyer, Simone I. Strasser et al.|Journal of Hepatology|2014Cited by 29